Bleomycin therapy in advanced hodgkin's disease and epidermoid cancers

Cancer. 1972 Jul;30(1):56-60. doi: 10.1002/1097-0142(197207)30:1<56::aid-cncr2820300109>3.0.co;2-l.
No abstract available

MeSH terms

  • Adenocarcinoma / drug therapy
  • Antibiotics, Antineoplastic / therapeutic use*
  • Bleomycin / administration & dosage
  • Bleomycin / adverse effects
  • Bleomycin / therapeutic use
  • Carcinoma, Squamous Cell / drug therapy
  • Female
  • Head and Neck Neoplasms / drug therapy
  • Hodgkin Disease / complications
  • Hodgkin Disease / drug therapy*
  • Humans
  • Lung Diseases / etiology
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Methotrexate / therapeutic use
  • Skin Neoplasms / drug therapy
  • Teratoma / drug therapy
  • Uterine Cervical Neoplasms / drug therapy
  • Vaginal Neoplasms / drug therapy

Substances

  • Antibiotics, Antineoplastic
  • Bleomycin
  • Methotrexate